IBDEI062 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5872,0)
 ;;=A4714^^38^413^27^^^^1
 ;;^UTILITY(U,$J,358.3,5872,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5872,1,2,0)
 ;;=2^A4714
 ;;^UTILITY(U,$J,358.3,5872,1,3,0)
 ;;=3^TREATED WATER PER GALLON
 ;;^UTILITY(U,$J,358.3,5873,0)
 ;;=A4706^^38^413^4^^^^1
 ;;^UTILITY(U,$J,358.3,5873,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5873,1,2,0)
 ;;=2^A4706
 ;;^UTILITY(U,$J,358.3,5873,1,3,0)
 ;;=3^BICARBONATE CONC SOL PER GALLON
 ;;^UTILITY(U,$J,358.3,5874,0)
 ;;=90965^^38^414^1^^^^1
 ;;^UTILITY(U,$J,358.3,5874,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5874,1,2,0)
 ;;=2^90965
 ;;^UTILITY(U,$J,358.3,5874,1,3,0)
 ;;=3^ESRD HOME PT SERV P MO AGE 12-19
 ;;^UTILITY(U,$J,358.3,5875,0)
 ;;=90966^^38^414^2^^^^1
 ;;^UTILITY(U,$J,358.3,5875,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5875,1,2,0)
 ;;=2^90966
 ;;^UTILITY(U,$J,358.3,5875,1,3,0)
 ;;=3^ESRD HOME PT SERV P MO AGE 20+
 ;;^UTILITY(U,$J,358.3,5876,0)
 ;;=90960^^38^415^6^^^^1
 ;;^UTILITY(U,$J,358.3,5876,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5876,1,2,0)
 ;;=2^90960
 ;;^UTILITY(U,$J,358.3,5876,1,3,0)
 ;;=3^ESRD SRV 4 VISITS P MO 20+
 ;;^UTILITY(U,$J,358.3,5877,0)
 ;;=90961^^38^415^4^^^^1
 ;;^UTILITY(U,$J,358.3,5877,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5877,1,2,0)
 ;;=2^90961
 ;;^UTILITY(U,$J,358.3,5877,1,3,0)
 ;;=3^ESRD SRV 2-3 VSTS P MO 20+
 ;;^UTILITY(U,$J,358.3,5878,0)
 ;;=90962^^38^415^2^^^^1
 ;;^UTILITY(U,$J,358.3,5878,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5878,1,2,0)
 ;;=2^90962
 ;;^UTILITY(U,$J,358.3,5878,1,3,0)
 ;;=3^ESRD SERV 1 VISIT P MO 20+
 ;;^UTILITY(U,$J,358.3,5879,0)
 ;;=90970^^38^415^7^^^^1
 ;;^UTILITY(U,$J,358.3,5879,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5879,1,2,0)
 ;;=2^90970
 ;;^UTILITY(U,$J,358.3,5879,1,3,0)
 ;;=3^PER DAY;LESS THAN A MONTH
 ;;^UTILITY(U,$J,358.3,5880,0)
 ;;=A4253^^38^416^7^^^^1
 ;;^UTILITY(U,$J,358.3,5880,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5880,1,2,0)
 ;;=2^A4253
 ;;^UTILITY(U,$J,358.3,5880,1,3,0)
 ;;=3^BLOOD GLUCOSE/REAGENT STRIPS
 ;;^UTILITY(U,$J,358.3,5881,0)
 ;;=80202^^38^416^5^^^^1
 ;;^UTILITY(U,$J,358.3,5881,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5881,1,2,0)
 ;;=2^80202
 ;;^UTILITY(U,$J,358.3,5881,1,3,0)
 ;;=3^ASSAY OF VANCOMYCIN
 ;;^UTILITY(U,$J,358.3,5882,0)
 ;;=87040^^38^416^6^^^^1
 ;;^UTILITY(U,$J,358.3,5882,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5882,1,2,0)
 ;;=2^87040
 ;;^UTILITY(U,$J,358.3,5882,1,3,0)
 ;;=3^BLOOD CULTURE FOR BACTERIA
 ;;^UTILITY(U,$J,358.3,5883,0)
 ;;=82507^^38^416^4^^^^1
 ;;^UTILITY(U,$J,358.3,5883,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5883,1,2,0)
 ;;=2^82507
 ;;^UTILITY(U,$J,358.3,5883,1,3,0)
 ;;=3^ASSAY OF CITRATE
 ;;^UTILITY(U,$J,358.3,5884,0)
 ;;=80329^^38^416^1^^^^1
 ;;^UTILITY(U,$J,358.3,5884,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5884,1,2,0)
 ;;=2^80329
 ;;^UTILITY(U,$J,358.3,5884,1,3,0)
 ;;=3^ANALGESIC,NON-OPIOID 1-2 TESTING
 ;;^UTILITY(U,$J,358.3,5885,0)
 ;;=80330^^38^416^2^^^^1
 ;;^UTILITY(U,$J,358.3,5885,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5885,1,2,0)
 ;;=2^80330
 ;;^UTILITY(U,$J,358.3,5885,1,3,0)
 ;;=3^ANALGESIC,NON-OPIOID 3-5 TESTING
 ;;^UTILITY(U,$J,358.3,5886,0)
 ;;=80331^^38^416^3^^^^1
 ;;^UTILITY(U,$J,358.3,5886,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5886,1,2,0)
 ;;=2^80331
 ;;^UTILITY(U,$J,358.3,5886,1,3,0)
 ;;=3^ANALGESIC,NON-OPIOID 6 OR MORE TESTING
 ;;^UTILITY(U,$J,358.3,5887,0)
 ;;=A4216^^38^417^39^^^^1
 ;;^UTILITY(U,$J,358.3,5887,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5887,1,2,0)
 ;;=2^A4216
 ;;^UTILITY(U,$J,358.3,5887,1,3,0)
 ;;=3^STERILE WATER/SALINE, 10 ML
 ;;^UTILITY(U,$J,358.3,5888,0)
 ;;=B4164^^38^417^35^^^^1
 ;;^UTILITY(U,$J,358.3,5888,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5888,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,5888,1,3,0)
 ;;=3^PARENTERAL 50% DEXTROSE SOLU
 ;;^UTILITY(U,$J,358.3,5889,0)
 ;;=B9006^^38^417^36^^^^1
 ;;^UTILITY(U,$J,358.3,5889,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5889,1,2,0)
 ;;=2^B9006
 ;;^UTILITY(U,$J,358.3,5889,1,3,0)
 ;;=3^PARENTERAL INFUS PUMP STATIO
 ;;^UTILITY(U,$J,358.3,5890,0)
 ;;=E1520^^38^417^21^^^^1
 ;;^UTILITY(U,$J,358.3,5890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5890,1,2,0)
 ;;=2^E1520
 ;;^UTILITY(U,$J,358.3,5890,1,3,0)
 ;;=3^HEPARIN INFUSION PUMP
 ;;^UTILITY(U,$J,358.3,5891,0)
 ;;=J0713^^38^417^9^^^^1
 ;;^UTILITY(U,$J,358.3,5891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5891,1,2,0)
 ;;=2^J0713
 ;;^UTILITY(U,$J,358.3,5891,1,3,0)
 ;;=3^CEFTAZIDIME INJ PER 500 MG
 ;;^UTILITY(U,$J,358.3,5892,0)
 ;;=J0735^^38^417^10^^^^1
 ;;^UTILITY(U,$J,358.3,5892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5892,1,2,0)
 ;;=2^J0735
 ;;^UTILITY(U,$J,358.3,5892,1,3,0)
 ;;=3^CLONIDINE HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,5893,0)
 ;;=J1200^^38^417^15^^^^1
 ;;^UTILITY(U,$J,358.3,5893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5893,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,5893,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL PER 50 MG
 ;;^UTILITY(U,$J,358.3,5894,0)
 ;;=J1270^^38^417^16^^^^1
 ;;^UTILITY(U,$J,358.3,5894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5894,1,2,0)
 ;;=2^J1270
 ;;^UTILITY(U,$J,358.3,5894,1,3,0)
 ;;=3^DOXERCALCIFEROL INJ PER 1 MCG
 ;;^UTILITY(U,$J,358.3,5895,0)
 ;;=J1580^^38^417^20^^^^1
 ;;^UTILITY(U,$J,358.3,5895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5895,1,2,0)
 ;;=2^J1580
 ;;^UTILITY(U,$J,358.3,5895,1,3,0)
 ;;=3^GARAMYCIN GENTAMICIN PER 80 MG
 ;;^UTILITY(U,$J,358.3,5896,0)
 ;;=J1642^^38^417^22^^^^1
 ;;^UTILITY(U,$J,358.3,5896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5896,1,2,0)
 ;;=2^J1642
 ;;^UTILITY(U,$J,358.3,5896,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 10 U (FLUSH)
 ;;^UTILITY(U,$J,358.3,5897,0)
 ;;=J1644^^38^417^23^^^^1
 ;;^UTILITY(U,$J,358.3,5897,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5897,1,2,0)
 ;;=2^J1644
 ;;^UTILITY(U,$J,358.3,5897,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 1000 U
 ;;^UTILITY(U,$J,358.3,5898,0)
 ;;=J2060^^38^417^29^^^^1
 ;;^UTILITY(U,$J,358.3,5898,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5898,1,2,0)
 ;;=2^J2060
 ;;^UTILITY(U,$J,358.3,5898,1,3,0)
 ;;=3^LORAZEPAM INJ PER 2 MG
 ;;^UTILITY(U,$J,358.3,5899,0)
 ;;=J2405^^38^417^33^^^^1
 ;;^UTILITY(U,$J,358.3,5899,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5899,1,2,0)
 ;;=2^J2405
 ;;^UTILITY(U,$J,358.3,5899,1,3,0)
 ;;=3^ONDANSETRON HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,5900,0)
 ;;=J2997^^38^417^3^^^^1
 ;;^UTILITY(U,$J,358.3,5900,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5900,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,5900,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT PER 1 MG
 ;;^UTILITY(U,$J,358.3,5901,0)
 ;;=J3260^^38^417^41^^^^1
 ;;^UTILITY(U,$J,358.3,5901,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5901,1,2,0)
 ;;=2^J3260
 ;;^UTILITY(U,$J,358.3,5901,1,3,0)
 ;;=3^TOBRAMYCIN SULFATE PER 80 MG
 ;;^UTILITY(U,$J,358.3,5902,0)
 ;;=J7682^^38^417^40^^^^1
 ;;^UTILITY(U,$J,358.3,5902,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5902,1,2,0)
 ;;=2^J7682
 ;;^UTILITY(U,$J,358.3,5902,1,3,0)
 ;;=3^TOBRAMYCIN NON-COM UNIT 300 MG
 ;;^UTILITY(U,$J,358.3,5903,0)
 ;;=P9047^^38^417^2^^^^1
 ;;^UTILITY(U,$J,358.3,5903,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5903,1,2,0)
 ;;=2^P9047
 ;;^UTILITY(U,$J,358.3,5903,1,3,0)
 ;;=3^ALBUMIN (HUMAN), 25%, 50ML
 ;;^UTILITY(U,$J,358.3,5904,0)
 ;;=J3370^^38^417^43^^^^1
 ;;^UTILITY(U,$J,358.3,5904,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5904,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,5904,1,3,0)
 ;;=3^VANCOMYCIN HCL 500 MG
 ;;^UTILITY(U,$J,358.3,5905,0)
 ;;=J0636^^38^417^5^^^^1
 ;;^UTILITY(U,$J,358.3,5905,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5905,1,2,0)
 ;;=2^J0636
 ;;^UTILITY(U,$J,358.3,5905,1,3,0)
 ;;=3^CALCITRIOL INJ PER 0.1 MCG
 ;;^UTILITY(U,$J,358.3,5906,0)
 ;;=J0882^^38^417^11^^^^1
 ;;^UTILITY(U,$J,358.3,5906,1,0)
 ;;=^358.31IA^3^2
